Vitamin cocktail may soothe chemo nerve damage
NCT ID NCT07022938
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a dietary supplement containing ingredients like palmitoylethanolamide, alpha lipoic acid, and several B vitamins to see if it could reduce nerve pain in cancer patients receiving chemotherapy. 71 newly diagnosed patients who had not yet started treatment took either the supplement or a placebo. The goal was to measure changes in neuropathic pain symptoms and nerve function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dietary supplement (palmitoylethanolamide, alpha lipoic acid, vitamins B1, B6, B12, E, nicotinamide, magnesium, zinc, superoxide dismutase)
What this could lead to
If it works, this supplement could offer a simple way to reduce nerve pain caused by chemotherapy, improving quality of life for cancer patients.
What could go wrong
This is a small, completed phase 4 trial with only 71 participants. The supplement may not work for everyone, and results may not apply to all chemotherapy types. Dietary supplements can also interact with other medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University General Hospital of Thessaloniki AHEPA
Thessaloniki, Greece